Results 61 to 70 of about 3,674 (207)

Neurofibromatose Tipo 1: Envolvimento Cutâneo Exuberante

Acta Médica Portuguesa, 2020
N/a.
Sandra Ferreira, Manuela Selores, Tiago Torres   +2 more
doaj   +1 more source

Comparação entre tomografia computadorizada e ressonância magnética nos esclarecimento etiológico de epilepsias parciais. [PDF]

, 2001
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Clínica Médica, Curso de Medicina, Florianópolis ...
Alcantara, Karla de Bem
core  

Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1

Skin Research and Technology, Volume 30, Issue 9, September 2024.
Abstract Background Cutaneous neurofibromas (cNFs) are a major cause of disfigurement in patients with Neurofibromatosis Type 1 (NF1). However, clinical trials investigating cNF treatments lack standardised outcome measures to objectively evaluate changes in cNF size and appearance.
Jonathan C. L. Lau, Jane Fleming, Martin Good, Adrian Lim, Rebecca B. Saunderson, Tai A. Phan, Timothy Schlub, Sue‐Faye Siow, Nanette Lacson, Carlos Romo, Jaishri Blakely, Christina Bergqvist, Yemima D. Berman   +12 more
wiley   +1 more source

Neurofibromatosis: part 2 – clinical management

Arquivos de Neuro-Psiquiatria, 2015
Part 1 of this guideline addressed the differential diagnosis of the neurofibromatoses (NF): neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH). NF shares some features such as the genetic origin of the neural tumors
Pollyanna Barros Batista, Eny Maria Goloni Bertollo, Danielle de Souza Costa, Lucas Eliam, Karin Soares Gonçalves Cunha, José Renan Cunha-Melo, Luiz Guilherme Darrigo Junior, Mauro Geller, Ingrid Faria Gianordoli-Nascimento, Luciana Gonçalves Madeira, Hérika Martins Mendes, Débora Marques de Miranda, Nikolas Andre Mata-Machado, Eric Grossi Morato, Érika Cristina Pavarino, Luciana Baptista Pereira, Nilton Alves de Rezende, Luíza de Oliveira Rodrigues, Jorge Bezerra Cavalcanti Sette, Carla Menezes da Silva, Juliana Ferreira de Souza, Márcio Leandro Ribeiro de Souza, Aline Stangherlin Martins, Eugênia Ribeiro Valadares, Paula Vieira Teixeira Vidigal, Vanessa Waisberg, Yehuda Waisberg, Luiz Oswaldo Carneiro Rodrigues   +27 more
doaj   +1 more source

Syndrome in question [PDF]

, 2016
Neurofibromatosis is extremely variable in its presentation. Segmental neurofibromatosis (SNF), which corresponds to NF-type 5 in the Riccardi classification, is a rare disorder. It may go unrecognized if few lesions are observed.
Carvalho, S., Horta, M., Oujo, E., Rosmaninho, A.   +3 more
core   +3 more sources

Diagnostic contribution of visual electrophysiologic assessment in patients from a university hospital [PDF]

, 2003
PURPOSE: To determine the frequency of diagnostic categories obtained in a clinical vision electrophysiology laboratory at a university hospital. METHODS: Patients who underwent visual electrodiagnostic testing from October 1998 to October 2000 (N=570 ...
Berezovsky, Adriana, Fantini, Sérgio Costa, Sacai, Paula Yuri, Salomão, Solange Rios   +3 more
core   +3 more sources

Asymmetry of thalamic hypometabolism on FDG‐PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden

Journal of Neuroimaging, Volume 34, Issue 1, Page 138-144, January/February 2024.
Abstract Background and Purpose Thalamic hypometabolism is a consistent finding in brain PET with F‐18 fluorodeoxyglucose (FDG) in patients with neurofibromatosis type 1 (NF1). However, the pathophysiology of this metabolic alteration is unknown. We hypothesized that it might be secondary to disturbance of peripheral input to the thalamus by NF1 ...
Cansu Özden, Victor‐Felix Mautner, Said Farschtschi, Isabel Molwitz, Inka Ristow, Peter Bannas, Lennart Well, Susanne Klutmann, Gerhard Adam, Ivayla Apostolova, Ralph Buchert   +10 more
wiley   +1 more source

Neurofibromatoses: part 1 ? diagnosis and differential diagnosis

Arquivos de Neuro-Psiquiatria, 2014
Neurofibromatoses (NF) are a group of genetic multiple tumor growing predisposition diseases: neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH), which have in common the neural origin of tumors and cutaneous signs ...
Luiz Oswaldo Carneiro Rodrigues, Pollyanna Barros Batista, Eny Maria Goloni-Bertollo, Danielle de Souza-Costa, Lucas Eliam, Miguel Eliam, Karin Soares Gonçalves Cunha, Luiz Guilherme Darrigo Junior, José Roberto Lopes Ferraz Filho, Mauro Geller, Ingrid F. Gianordoli-Nascimento, Luciana Gonçalves Madeira, Leandro Fernandes Malloy-Diniz, Hérika Martins Mendes, Débora Marques de Miranda, Erika Cristina Pavarino, Luciana Baptista-Pereira, Nilton A. Rezende, Luíza de Oliveira Rodrigues, Carla Menezes da Silva, Juliana Ferreira de Souza, Márcio Leandro Ribeiro de Souza, Aline Stangherlin, Eugênia Ribeiro Valadares, Paula Vieira Teixeira Vidigal   +24 more
doaj   +1 more source

Prevalência de surdez em crianças de 4 anos de idade [PDF]

, 2013
A pertinência deste projeto prende-se com o facto da Surdez Infantil constituir um problema de Saúde Pública devido, quer à elevada prevalência, quer às múltiplas consequências que acarreta. Na criança pode observar-se atraso no desenvolvimento cognitivo,
Sousa, Aida
core  

Neurofibromatose tipo ii : a propósito de casos clínicos

Revista Portuguesa Otorrinolaringologia e Cirurgia de Cabeça e Pescoço, 2017
Introdução: A neurofibromatose tipo II é uma doença autossómica dominante rara, caracterizada pelo aparecimento de múltiplas neoplasias benignas no sistema nervoso. As manifestações clínicas são variadas.
Miguel Silva, José Romão, António Diogo de Paiva   +2 more
doaj   +1 more source